EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease

Sean Michael Carr, Tharmarajan Ramprasath, Ming-Hui Zou iD

Cells · 2026

DOI: 10.3390/cells15211946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Sean Michael Carr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Indican, Actins, Renal Insufficiency, Chronic, Vascular Remodeling. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nature Science Foundation of China, Tianjin Key Medical Discipline Construction Project, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chronic kidney disease (CKD) worsens outcomes of peripheral artery diseases (PADs), partly through impaired vascular regeneration and microvascular remodeling. CKD promotes the accumulation of uremic toxins, but their contributions to microvascular dysfunction remain poorly understood. This study investigated the effects of uremic toxin indoxyl sulfate (IS) on vascular smooth muscle cell (VSMC) function and microvascular remodeling in a mouse model of CKD.

Methods

C57BL6/J mice were fed 0.25% adenine diet for 10 days to induce CKD. CKD mice underwent hindlimb ligation surgery. VSMC migration assays, microscopy, and Western blotting were utilized to elucidate the underlying mechanisms underlying the IS-induced impairment of vascular remodeling.

Results

CKD mice exhibited significantly impaired blood flow restoration (44.7% relative blood flow) compared with controls (82.6% relative blood flow) accompanied by a reduced α-smooth muscle expression and decreased formation of smooth muscle-covered micro vessels in ischemic limbs. Wound healing and transwell migrations assays demonstrated IS significantly reduced VSMC motility. IS-exposure also disrupted actin cytoskeletal organization, impaired cell attachment, reduced cell size, and decreased focal adhesion formation. Mechanistically, IS reduced focal adhesion kinase (FAK) expression, impairing VSMC adhesion and migration. Reduced FAK signaling was associated with decreased N-WASP expression and suppression of the Arp2/3 complex, which regulates actin polymerization and cytoskeletal remodeling. These alterations suggest that IS disrupts the cellular processes required for VSMC recruitment and structural remodeling of the microvascular, potentially limiting vessel maturation and stabilization during ischemic recovery.

Conclusions

IS impairs VSMC migration and cytoskeletal organization through the disruption of the FAK-N-WASP-Arp2/3 signaling axis, contributing to defective microvascular remodeling and impaired perfusion recovery in CKD-associated PAD. These findings identify uremic toxin-mediated cytoskeletal dysfunction as a potential therapeutic target for improving microvascular regeneration and vascular recovery in patients with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndicanActinsRenal Insufficiency, ChronicVascular RemodelingFocal Adhesion Kinase 1MicrovesselsFocal Adhesion Protein-Tyrosine KinasesAnimalsDisease Models, AnimalMiceMice, Inbred C57BLCell MovementMaleMuscle, Smooth, VascularSignal TransductionMyocytes, Smooth Muscle

Stichwörter der Autor:innen

chronic kidney diseasefocal adhesion kinaseindoxyl sulfatemicrovascular remodeling

Substanzen

IndicanActinsFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesPtk2 protein, mouse

Autor:innen und Institutionen

  • Center for Molecular and Translational Medicine, Georgia State University, Atlanta, GA 30303, USA.
  • Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.

ORCID-Profile: Ming-Hui Zou

Förderung

  • Nature Science Foundation of China
  • Tianjin Key Medical Discipline Construction Project
  • American Heart Association

Zitieren

APA

Carr, S. M., Ramprasath, T., & Zou, M. H. (2026). Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease. Cells. https://doi.org/10.3390/cells15211946

Vancouver

Carr SM, Ramprasath T, Zou MH. Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease. Cells. 2026. doi:10.3390/cells15211946

BibTeX
@article{Carr2026,
  author = {Carr, Sean Michael and Ramprasath, Tharmarajan and Zou, Ming-Hui},
  title = {Inhibition of FAK-Actin Pathway by Indoxyl Sulfate Suppresses Microvascular Remodeling in a Mouse Model of Chronic Kidney Disease},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15211946}
}
Kostenlos starten →